Anzeige
Erschienen in:
01.01.2016 | Original Article
Test–retest reproducibility of [11C]PBR28 binding to TSPO in healthy control subjects
Erschienen in: European Journal of Nuclear Medicine and Molecular Imaging | Ausgabe 1/2016
Einloggen, um Zugang zu erhaltenAbstract
Purpose
The PET radioligand [11C]PBR28 binds to the translocator protein (TSPO), a marker of brain immune activation. We examined the reproducibility of [11C]PBR28 binding in healthy subjects with quantification on a regional and voxel-by-voxel basis. In addition, we performed a preliminary analysis of diurnal changes in TSPO availability.
Methods
Twelve subjects were examined using a high-resolution research tomograph and [11C]PBR28, six in the morning and afternoon of the same day, and six in the morning on two separate days. Regional volumes of distribution (V
T) were derived using a region-of-interest based two-tissue compartmental analysis (2TCM), as well as a parametric approach. Metabolite-corrected arterial plasma was used as input function.
Results
For the whole sample, the mean absolute variability in V
T in the grey matter (GM) was 18.3 ± 12.7 %. Intraclass correlation coefficients in GM regions ranged from 0.90 to 0.94. Reducing the time of analysis from 91 to 63 min yielded a variability of 16.9 ± 14.9 %. There was a strong correlation between the parametric and 2TCM-derived GM values (r = 0.99). A significant increase in GM V
T was observed between the morning and afternoon examinations when using secondary methods of quantification (p = 0.028). In the subjects examined at the same time of the day, the absolute variability was 15.9 ± 12.2 % for the 91-min 2TCM data.
Conclusion
V
T of [11C]PBR28 binding showed medium reproducibility and high reliability in GM regions. Our findings support the use of parametric approaches for determining [11C]PBR28 V
T values, and indicate that the acquisition time could be shortened. Diurnal changes in TSPO binding in the brain may be a potential confounder in clinical studies and should be investigated further.